Protein-targeting Therapy Found to Lessen Inflammation in Preclinical Study

Protein-targeting Therapy Found to Lessen Inflammation in Preclinical Study

285256

Protein-targeting Therapy Found to Lessen Inflammation in Preclinical Study

A novel medication targeting the protein folate receptor-beta (FR-beta) decreased inflammation and brain damage in a rat model of multiple sclerosis (MS). The findings were published in the Journal of Neuroinflammation, in the study “Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis.” MS is caused by the immune system attacking the nervous system, and one type of immune cell involved in this attack is the macrophage. In animal models of…

You must be logged in to read/download the full post.